quinazolines has been researched along with Ectropion in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Molina-Prat, N; Saint-Jean, A; Sainz de la Maza, M | 1 |
Chi, SC; Chow, VW; Jhanji, V | 1 |
Molina, JJ; Molina-Prat, N; Morral, M; Quintana, R; Saint-Jean, A; Sainz de la Maza, M; Torras, J | 1 |
3 other study(ies) available for quinazolines and Ectropion
Article | Year |
---|---|
Author reply: To PMID 22584020.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Corneal Perforation; Ectropion; ErbB Receptors; Female; Humans; Male; Protein Kinase Inhibitors; Quinazolines | 2013 |
Erlotinib-related corneal melting.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Corneal Perforation; Ectropion; ErbB Receptors; Female; Humans; Male; Protein Kinase Inhibitors; Quinazolines | 2013 |
Ocular adverse events of systemic inhibitors of the epidermal growth factor receptor: report of 5 cases.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Colorectal Neoplasms; Corneal Perforation; Ectropion; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Keratoplasty, Penetrating; Lung Neoplasms; Male; Middle Aged; Panitumumab; Protein Kinase Inhibitors; Quinazolines; Retrospective Studies; Visual Acuity | 2012 |